Exercise Intensity for Cardiorespiratory Fitness
(REVISE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how various exercise types affect cardiorespiratory fitness and overall heart health. Researchers aim to determine whether increasing exercise frequency or intensity benefits everyone or if some individuals see no improvement. Participants will join groups with different exercise routines, ranging from low to high intensity and duration. Individuals with a sedentary lifestyle (exercising once a week or less), stable weight, and a BMI between 20 and 40 may be suitable for this trial. The goal is to identify whether some people require alternative strategies beyond standard exercise guidelines. As an unphased trial, this study provides a unique opportunity to enhance understanding of personalized exercise strategies for improved heart health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that high-intensity interval training (HIIT) is generally safe and most people tolerate it well. Studies have found that HIIT can enhance exercise capacity and improve heart and lung health without causing major problems. The dropout rate from these studies is about 23%, indicating that most participants manage this type of exercise.
For those engaging in low-intensity exercise, current research suggests it's safe and beneficial for improving heart and lung health. Even short exercise sessions, like 10 to 15 minutes, can be effective and reduce health risks.
Overall, past research has shown that different levels of exercise intensity and duration in this study are safe. Always consult a healthcare provider before starting any new exercise program, especially if existing health issues are present.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how varying amounts and intensities of exercise can boost cardiorespiratory fitness. Unlike typical exercise recommendations that often suggest moderate activity, this trial dives into the effects of high-intensity workouts in different doses. By understanding how these different exercise regimens impact fitness, the trial aims to uncover more personalized and effective exercise strategies. This could lead to new guidelines that optimize heart and lung health for people with diverse fitness levels and needs.
What evidence suggests that this trial's exercise treatments could be effective for improving cardiorespiratory fitness?
Research shows that high-intensity interval training (HIIT), experienced in this trial as either a high or low amount, greatly improves heart and lung fitness in adults. Studies have found that both high and low amounts of HIIT enhance fitness more than regular moderate exercise or no exercise. In this trial, some participants will engage in low-amount, low-intensity exercise, which evidence suggests can still reduce the risk of heart disease. This indicates that any regular exercise, whether intense or not, can improve heart and lung health. Overall, exercising regularly, regardless of intensity, positively impacts fitness and health.36789
Who Is on the Research Team?
Robert Ross, PhD
Principal Investigator
Queen's University
Are You a Good Fit for This Trial?
This trial is for adults who lead a sedentary lifestyle, exercising no more than once a week, have had a stable weight for the past 6 months, and have a BMI between 20-40. It's not suitable for individuals with diabetes, current smokers, those planning to move soon or anyone with physical impairments that make exercise difficult or unsafe.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
First Line Therapy
Participants engage in 150 minutes per week of moderate physical activity (MPA) for 16 weeks to assess initial response in cardiorespiratory fitness (CRF) and cardiometabolic risk factors.
Increased Exercise Intensity/Amount
Participants who do not respond to first line therapy increase exercise intensity or amount for an additional 16 weeks to evaluate changes in CRF and cardiometabolic risk factors.
Follow-up
Participants are monitored for safety and effectiveness after the exercise intervention phases.
What Are the Treatments Tested in This Trial?
Interventions
- High amount, high intensity exercise
- Low amount, high intensity exercise
- Low amount, low intensity exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Robert Ross, PhD
Lead Sponsor
Robert Ross, PhD
Lead Sponsor
Queen's University
Lead Sponsor